57
Participants
Start Date
July 31, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
valganciclovir [Valcyte]
Oral, daily for up to 200 days.
Children'S Hospital At Westmead; Department of Nephrology, Westmead
Royal Children'S Hospital; Department of Nephrology, Parkville
Mater Childrens Hospital, South Brisbane, Herston
Centenario Hospital Miguel Hidalgo, Aguascalientes
Universitätsklinikum für Kinder und Jugendmedizin Hamburg, Hamburg
Hospital Universitario La Paz: Nefrologia Pediatrica, Madrid
KfH Nierenzentrum für Kinder und Jugendliche an der MHH Hannover, Hanover
Hospital Universitario Virgen del Rocio; Servicio de Nefrologia Pediatrica, Seville
Sahlgrenska Sjukhuset; Transplantationskirurgiska Kliniken, Gothenburg
CHU de Nantes - Service de pédiatrie, Nantes
Klinik und Poliklinik für Kinder- und Jugendmedizin- Köln, Uniklinik Köln, Cologne
Instituto Mexicano de Transplantes, Cuernavaca
Klinik Kinderheikunde I des Zentrums für Kinder- und Jugendmedizin, Universität Heidelberg, Heidelberg
Hôpital Robert Debré; Nephrologie pediatrique, Paris
Hop Necker Enfants Malades;Nephrologie Pediatrique, Paris
Uni of Utah Health Science Center; Pediatric Nephrology, Salt Lake City
University of Florida Pediatric Nephrology, Gainesville
UCLA Center For Health Sciences; Division of Pediatric Nephrology, Los Angeles
Mount Sinai Medical Center, New York
Universidade Federal de Sao Paulo - UNIFESP, São Paulo
Hospital Infantil de Mexico Federico Gomez, México
Hospital Universitari Vall d'Hebron, Barcelona
Birmingham Children's Hospital, Birmingham
Bristol Royal Hospital For Children, Bristol
Royal Hospital For Sick Children; Dept. of Child Health, Glasgow
Hoffmann-La Roche
INDUSTRY